• Explore /
  • Poster
  • / Nivolumab (nivo) in patients (pts) with advanced (adv) NSCLC and central nervous system (CNS) metastases (mets).

Nivolumab (nivo) in patients (pts) with advanced (adv) NSCLC and central nervous system (CNS) metastases (mets).

Abstract Poster

Authors

Jonathan Goldman

Jonathan Wade Goldman

UCLA, Jonsson Comprehensive Cancer Center, Los Angeles, CA

Jonathan Wade Goldman , Lucio Crino , Everett E. Vokes , Esther Holgado , Karen L. Reckamp , Adam Pluzanski , David R. Spigel , Martin Kohlhaeufl , Marina Chiara Garassino , Laura Quan Man Chow , Scott N. Gettinger , David E. Gerber , Libor Havel , Suresh S. Ramalingam , Grace K. Dy , William J. Geese , Ang Li , Anne Blackwood-Chirchir , Diane I. Healey , Julie R. Brahmer

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT01721759; NCT01642004; NCT01673867

Citation

J Clin Oncol 34, 2016 (suppl; abstr 9038)

DOI

10.1200/JCO.2016.34.15_suppl.9038

Abstract #

9038

Poster Bd #

361

Abstract Disclosures

Similar Posters

First Author: Hossein Borghaei

First Author: Thierry Landre

First Author: Meena Venkatachalam

First Author: Germán Corredor